ChatGPT, Claude, or Gemini? Big Pharma Is Choosing Sides
Major pharmaceutical companies are increasingly selecting specific AI models—such as ChatGPT, Claude, or Gemini—for drug discovery and development, tailoring their choice based on each model's strengths in data analysis, molecule design, and regulatory compliance.